Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis

OBJECTIVES: In March 2020, the Substance Abuse and Mental Health Services Administration permitted Opioid Treatment Programs (OTPs) to relax restrictions on take-home methadone and promoted telehealth to minimize potential exposures to COVID-19. We assessed the effects of COVID-19-related changes on...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffman, Kim A., Foot, Canyon, Levander, Ximena A., Cook, Ryan, Terashima, Javier Ponce, McIlveen, John W., Korthuis, P. Todd, McCarty, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080674/
https://www.ncbi.nlm.nih.gov/pubmed/35589443
http://dx.doi.org/10.1016/j.jsat.2022.108801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080674/
https://www.ncbi.nlm.nih.gov/pubmed/35589443
http://dx.doi.org/10.1016/j.jsat.2022.108801

Ejemplares similares